
Andrew T. Templin, PhD
Assistant Professor of Medicine
Adjunct Assistant Professor of Biochemistry and Molecular Biology
- Phone
- (317) 983-3350
- Address
-
1210 Waterway Blvd
Indianapolis, IN 46202 - PubMed:
-
Bio
Andrew Templin is an Assistant Professor of Medicine at the Indiana University School of Medicine and a Research Health Scientist at the Richard L. Roudebush VA Medical Center.
After earning his Bachelor of Science degree from the Indiana University Hutton Honors College, Andrew conducted medical research at the Northwestern University Feinberg School of Medicine. He then completed his Ph.D. training in the Indiana University Department of Cellular and Integrative Physiology, followed by postdoctoral training in the University of Washington Department of Medicine and the VA Puget Sound Health Care System. Prior to joining the faculty at Indiana University, Andrew served as an Acting Instructor of Medicine at the University of Washington and as a Research Health Scientist at the VA Puget Sound.
Dr. Templin’s research has been supported by funding from the National Institutes of Health, the U.S. Department of Veterans Affairs, the American Diabetes Association, the American Chemical Society, and the Showalter Research Trust. His work has been published in leading journals including Diabetes, Diabetologia, Diabetes Care, Cell Death and Disease, Journal of Biological Chemistry, and Proceedings of the National Academy of Sciences.
Andrew is a native Hoosier who enjoys travel, sports, gardening, golden retrievers, and spending time with family.
| Year | Degree | Institution |
|---|---|---|
| 2014 | Fellowship | University of Washington |
| 2014 | PhD | Indiana University |
| 2006 | BS | Indiana University |
Dr. Templin’s research focuses on understanding the relationship between beta-cell failure and islet immune responses in both major forms of diabetes. Emphasis is placed on the concept that beta-cell intrinsic properties are drivers of islet inflammation and beta-cell autoimmunity, and that together these promote a cycle of beta-cell cytotoxicity that leads to diabetes. The Templin Lab is particularly interested in mechanisms of inflammatory, lytic beta-cell death and the role of such pathways in promoting islet inflammation and beta-cell loss in diabetes. These lines of research utilize in vitro models of beta-cell demise and in vivo models of islet amyloid formation, islet inflammation, and beta-cell cytotoxicity to examine how beta-cells themselves promote islet inflammation in the pathogenesis of diabetes. Through this work, the Templin Lab aims to advance our understanding of beta-cell failure in diabetes and improve the health of individuals afflicted with this disease.